In a Sign of Gene-Editing Frenzy, Startup Pitches Editing without CRISPR

September 4, 2017

(MIT Technology Review) – The gene-editing system CRISPR is the hottest subject in biology because of the technique’s ability to change DNA letters and potentially cure genetic disease. So what could be better? What about a way to edit genes with no CRISPR at all. A startup called Homology Medicines says it has a way to do that. The Bedford, Massachusetts, company has raised an impressive $127 million to treat genetic diseases using viruses it claims are capable of efficiently repairing human genes, all on their own.